VYOME HOLDINGS, INC. Increase (Decrease) in Accounts Receivable
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Accounts Receivable of $1.86 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-12
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $22.66K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2024-09-30 was -$2.78K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2020 was -$285.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2019 was -$585.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2018 was -$3.35M, a 179.40% decline from fiscal 2017.
- VYOME HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2017 was $4.22M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.86K 10-Q · filed 2026-08-12 | |||
| 2025-09-30 | $22.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $20.71K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | -$1.95K 10-Q · filed 2026-08-12 | |||
| 2024-09-30 | -$2.78K derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14 | -$66.47K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$63.69K 8-K · filed 2025-09-02 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | $0.00 derived: sum of 2 quarters · filed 2021-05-12 | $0.00 derived: sum of 3 quarters · filed 2021-05-12 | -$461.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | -$461.00K derived: sum of 3 quarters · filed 2021-03-12 | -$285.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$461.00K derived: sum of 2 quarters · filed 2020-11-06 | -$285.00K 10-Q · filed 2020-11-06 | -$238.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | -$461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$285.00K 10-Q · filed 2020-07-30 | -$238.00K derived: sum of 3 quarters · filed 2021-05-12 | -$447.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | $176.00K 10-Q · filed 2021-05-12 | $223.00K derived: sum of 2 quarters · filed 2021-05-12 | $14.00K derived: sum of 3 quarters · filed 2021-05-12 | -$1.37M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$162.00K derived: sum of 2 quarters · filed 2021-03-12 | -$1.54M derived: sum of 3 quarters · filed 2021-03-12 | -$585.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.59M derived: sum of 2 quarters · filed 2020-11-06 | -$632.00K 10-Q · filed 2020-11-06 | -$2.54M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | -$1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$423.00K 10-Q · filed 2020-07-30 | -$2.33M derived: sum of 3 quarters · filed 2020-07-30 | -$2.60M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $959.00K 10-Q · filed 2020-06-19 | -$946.00K derived: sum of 2 quarters · filed 2020-06-19 | -$1.22M derived: sum of 3 quarters · filed 2020-06-19 | -$724.00K derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$2.18M derived: sum of 2 quarters · filed 2020-02-27 | -$1.68M derived: sum of 3 quarters · filed 2020-02-27 | -$3.35M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $222.00K derived: sum of 2 quarters · filed 2019-11-08 | -$1.45M 10-Q · filed 2019-11-08 | $260.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$1.17M 10-Q · filed 2019-07-24 | $534.00K derived: sum of 3 quarters · filed 2019-07-24 | $1.29M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | -$1.67M 10-Q · filed 2019-05-10 | $38.00K derived: sum of 2 quarters · filed 2019-05-10 | $796.00K derived: sum of 3 quarters · filed 2019-05-10 | $1.52M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.47M derived: sum of 2 quarters · filed 2019-02-22 | $3.19M derived: sum of 3 quarters · filed 2019-02-22 | $4.22M 10-K · filed 2019-02-22 |
| 2017-09-30 | $758.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $1.48M derived: sum of 2 quarters · filed 2018-11-02 | $2.52M 10-Q · filed 2018-11-02 | $2.52M derived: sum of 4 quarters · filed 2018-11-02 |
| 2017-06-30 | $722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.76M 10-Q · filed 2018-08-02 | $1.76M derived: sum of 3 quarters · filed 2018-08-02 | $1.76M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $1.03M 10-Q · filed 2018-05-10 | $1.03M derived: sum of 2 quarters · filed 2018-05-10 | $1.03M derived: sum of 3 quarters · filed 2018-05-10 | $1.03M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $0.00 derived: sum of 2 quarters · filed 2018-03-05 | $0.00 derived: sum of 3 quarters · filed 2018-03-05 | $0.00 10-K · filed 2018-03-05 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-11-03 | $0.00 10-Q · filed 2017-11-03 | $1.00K derived: sum of 4 quarters · filed 2018-03-05 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | $1.00K derived: sum of 3 quarters · filed 2018-03-05 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $1.00K derived: sum of 2 quarters · filed 2018-03-05 | ||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | -$96.00K 10-K · filed 2018-03-05 | ||
| 2015-09-30 | -$97.00K 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | -$83.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |